Contrasting Thermo Fisher Scientific (TMO) and Its Competitors

Thermo Fisher Scientific (NYSE: TMO) is one of 82 publicly-traded companies in the “Advanced Medical Equipment & Technology” industry, but how does it compare to its competitors? We will compare Thermo Fisher Scientific to related businesses based on the strength of its earnings, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Dividends

Thermo Fisher Scientific pays an annual dividend of $0.60 per share and has a dividend yield of 0.3%. Thermo Fisher Scientific pays out 10.2% of its earnings in the form of a dividend. As a group, “Advanced Medical Equipment & Technology” companies pay a dividend yield of 0.9% and pay out 26.0% of their earnings in the form of a dividend.

Earnings & Valuation

This table compares Thermo Fisher Scientific and its competitors revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Thermo Fisher Scientific $19.20 billion $4.81 billion 32.67
Thermo Fisher Scientific Competitors $2.06 billion $438.96 million -77.91

Thermo Fisher Scientific has higher revenue and earnings than its competitors. Thermo Fisher Scientific is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Insider and Institutional Ownership

83.5% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 51.1% of shares of all “Advanced Medical Equipment & Technology” companies are owned by institutional investors. 0.5% of Thermo Fisher Scientific shares are owned by insiders. Comparatively, 18.7% of shares of all “Advanced Medical Equipment & Technology” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Thermo Fisher Scientific and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Thermo Fisher Scientific 11.73% 15.94% 7.41%
Thermo Fisher Scientific Competitors -327.98% -35.76% -12.51%

Analyst Recommendations

This is a summary of recent ratings for Thermo Fisher Scientific and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Thermo Fisher Scientific 0 1 14 0 2.93
Thermo Fisher Scientific Competitors 266 1842 3298 105 2.59

Thermo Fisher Scientific currently has a consensus target price of $205.00, indicating a potential upside of 6.54%. As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 7.75%. Given Thermo Fisher Scientific’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Thermo Fisher Scientific is more favorable than its competitors.

Volatility and Risk

Thermo Fisher Scientific has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific’s competitors have a beta of 0.89, meaning that their average stock price is 11% less volatile than the S&P 500.

Summary

Thermo Fisher Scientific beats its competitors on 12 of the 15 factors compared.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables. The Analytical Instruments segment provides a range of instruments, consumables, software and services. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers controlled temperature technologies products, growth protection and separation products, and water and laboratory products.

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit